UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies

Rheumatology and therapy., 2024-06, Vol.11 (3), p.583-597

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

Pediatric rheumatology online journal, 2023-02, Vol.21 (1), p.20-20, Article 20

2023

Link zum Volltext

Verfügbarkeit prüfen

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Advances in rheumatology (London, England), 2021-01, Vol.61 (1), p.2-2, Article 2

2021

Link zum Volltext

Verfügbarkeit prüfen

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis

Dermatology and therapy, 2023-12, Vol.13 (12), p.3043-3055

2023

Link zum Volltext

Verfügbarkeit prüfen

Incidence of Antidrug Antibodies in Rheumatoid Arthritis Patients From Argentina Treated With Adalimumab, Etanercept, or Infliximab in a Real-World Setting

Journal of clinical rheumatology, 2018-06, Vol.24 (4), p.177

2018

Link zum Volltext

Verfügbarkeit prüfen

Predictors of response to etanercept-methotrexate treatment: a post hoc logistic regression analysis of a randomized, open-label study in Latin American patients with rheumatoid arthritis

Advances in rheumatology (London, England), 2021-09, Vol.61 (1), p.56-56, Article 56

2021

Link zum Volltext

Verfügbarkeit prüfen

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial

Journal of rheumatology, 2023-04, Vol.50 (4), p.478

2023

Link zum Volltext

Verfügbarkeit prüfen

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Rheumatology (Oxford, England), 2024-01, Vol.63 (1), p.140-148

2024

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials

Drugs & aging, 2019-09, Vol.36 (9), p.853-862

2019

Link zum Volltext

Verfügbarkeit prüfen

Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial

Medicine (Baltimore), 2018-09, Vol.97 (36), p.e11989

2018

Link zum Volltext

Verfügbarkeit prüfen

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?

Journal of clinical rheumatology, 2019-03, Vol.25 (2), p.91

2019

Link zum Volltext

Verfügbarkeit prüfen

Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis

Open access rheumatology: research and reviews, 2020-03 (1), p.275

2020

Link zum Volltext

Verfügbarkeit prüfen

Psoriasis in Latin America

Dermatology online journal, 2016-09, Vol.22 (9)

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis

Open access rheumatology: research and reviews, 2019-01, Vol.11, p.275-281

2019

Link zum Volltext

Verfügbarkeit prüfen

Subjective Global Assessment in the Clinical Setting

JPEN. Journal of parenteral and enteral nutrition, 2007-09, Vol.31 (5), p.406-409

2007

Link zum Volltext

Verfügbarkeit prüfen

Adverse Prognostic Role of IDH2 Mutations at Diagnosis and during Follow-up in Patients with Acute Myeloid Leukemia and Normal Karyotype

Blood, 2021-11, Vol.138 (Supplement 1), p.2366-2366

2021

Link zum Volltext

Verfügbarkeit prüfen

Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome

Leukemia & lymphoma, 2019-10, Vol.60 (12), p.3044-3050

2019

Link zum Volltext

Verfügbarkeit prüfen

Health Related Quality of Life of Long-Term Survivors of Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Chemotherapy

Blood, 2016-12, Vol.128 (22), p.2415-2415

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(16)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Portugiesisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(10)
Rheumatology
(10)
Etanercept
(7)
Treatment Outcome
(7)
Adult
(6)
Male
(6)
Arthritis
(5)
Female
(5)
Latin America
(5)
Middle Aged
(5)
Rheumatoid Arthritis
(5)
Aged
(4)
Arthritis, Rheumatoid - Drug Therapy
(4)
Clinical Trials
(4)
Etanercept - Therapeutic Use
(4)
Antirheumatic Agents - Adverse Effects
(3)
Antirheumatic Agents - Therapeutic Use
(3)
Clinical Outcomes
(3)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Electronic Journals Library
(13)
MEDLINE
(10)
Journals@Ovid
(7)
Ingenta
(6)
Single Journals
(6)
SpringerLink (Online service)
(6)
IngentaConnect Journals
(3)
Wiley Online Library
(2)
Nexis Uni
(2)
Taylor & Francis Online
(1)
Oxford Journals
(1)
Oxford Journals 2020 Medicine
(1)
Wiley Online Library Full Collection 2018
(1)
Taylor & Francis
(1)

9 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Long-term Etanercept Response for Patients with Radiographic Axial Spondyloarthritis Based on Achievement of Early, Intermediate, or Late Responses During Index Studies

Efficacy and safety of TNF inhibitors in the treatment of juvenile idiopathic arthritis: a systematic literature review

Prevalence, demographics, and clinical characteristics of Latin American patients with spondyloarthritis

Psychosocial Burden of Psoriasis: A Systematic Literature Review of Depression Among Patients with Psoriasis

Incidence of Antidrug Antibodies in Rheumatoid Arthritis Patients From Argentina Treated With Adalimumab, Etanercept, or Infliximab in a Real-World Setting

Predictors of response to etanercept-methotrexate treatment: a post hoc logistic regression analysis of a randomized, open-label study in Latin American patients with rheumatoid arthritis

Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV Trial

Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis

Efficacy and Safety of Etanercept in Elderly Patients with Rheumatoid Arthritis: A Post-Hoc Analysis of Randomized Controlled Trials

Maintenance of low disease activity and remission with etanercept-disease-modifying antirheumatic drug (DMARD) combination therapy compared with treatment with DMARDs alone in Latin American patients with active rheumatoid arthritis: Subset analysis of a randomized trial

Practical Guidance on Biosimilars, With a Focus on Latin America: What Do Rheumatologists Need to Know?

Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis

Psoriasis in Latin America

Clinical Improvements as Predictors of Improvements in Patient-Reported Outcomes: Post Hoc Analysis of a Randomized, Open-Label Study of Etanercept in Latin American Patients with Rheumatoid Arthritis

Subjective Global Assessment in the Clinical Setting

Adverse Prognostic Role of IDH2 Mutations at Diagnosis and during Follow-up in Patients with Acute Myeloid Leukemia and Normal Karyotype

Invasive pulmonary aspergillosis in acute leukemia: a still frequent condition with a negative impact on the overall treatment outcome

Postremission therapy with repeated courses of high‐dose cytarabine, idarubicin, and limited autologous stem cell support achieves a very good long‐term outcome in European leukemia net favorable and intermediate‐risk acute myeloid leukemia

Invasive Pulmonary Aspergillosis in Acute Leukemia in the Era of New Antifungal Treatment and Prophylaxis Is Still Frequent, Even in Patients with Acute Lymphoblastic Leukemia, and Adversely Affects the Overall Treatment Outcome. Results of a 5-Year Study at a Single Institution

Health Related Quality of Life of Long-Term Survivors of Acute Promyelocytic Leukemia Treated with All-Trans Retinoic Acid and Chemotherapy

Suchergebnisse filtern